ARTN plasma levels are reduced in patients with major depressive disorder (Pallanti et al., 2014), and intracerebroventricular administration of ARTN shows dose-dependent antidepressant effects in mice, potentially via modulation of neuronal plasticity (Mannelli et al., 2011). This evidence concerns the gene ARTN and major depressive disorder.